1. Home
  2. SNFCA vs VYGR Comparison

SNFCA vs VYGR Comparison

Compare SNFCA & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNFCA
  • VYGR
  • Stock Information
  • Founded
  • SNFCA 1965
  • VYGR 2013
  • Country
  • SNFCA United States
  • VYGR United States
  • Employees
  • SNFCA N/A
  • VYGR N/A
  • Industry
  • SNFCA Finance: Consumer Services
  • VYGR Biotechnology: Pharmaceutical Preparations
  • Sector
  • SNFCA Finance
  • VYGR Health Care
  • Exchange
  • SNFCA Nasdaq
  • VYGR Nasdaq
  • Market Cap
  • SNFCA 285.8M
  • VYGR 309.7M
  • IPO Year
  • SNFCA N/A
  • VYGR 2015
  • Fundamental
  • Price
  • SNFCA $13.26
  • VYGR $6.37
  • Analyst Decision
  • SNFCA
  • VYGR Strong Buy
  • Analyst Count
  • SNFCA 0
  • VYGR 9
  • Target Price
  • SNFCA N/A
  • VYGR $16.44
  • AVG Volume (30 Days)
  • SNFCA 63.8K
  • VYGR 584.2K
  • Earning Date
  • SNFCA 11-14-2024
  • VYGR 11-12-2024
  • Dividend Yield
  • SNFCA N/A
  • VYGR N/A
  • EPS Growth
  • SNFCA N/A
  • VYGR N/A
  • EPS
  • SNFCA 1.23
  • VYGR 0.47
  • Revenue
  • SNFCA $330,162,091.00
  • VYGR $163,784,000.00
  • Revenue This Year
  • SNFCA N/A
  • VYGR N/A
  • Revenue Next Year
  • SNFCA N/A
  • VYGR N/A
  • P/E Ratio
  • SNFCA $10.80
  • VYGR $14.09
  • Revenue Growth
  • SNFCA N/A
  • VYGR 3.40
  • 52 Week Low
  • SNFCA $6.19
  • VYGR $5.19
  • 52 Week High
  • SNFCA $13.50
  • VYGR $11.72
  • Technical
  • Relative Strength Index (RSI)
  • SNFCA 90.64
  • VYGR 53.48
  • Support Level
  • SNFCA $12.84
  • VYGR $5.54
  • Resistance Level
  • SNFCA $13.41
  • VYGR $7.44
  • Average True Range (ATR)
  • SNFCA 0.56
  • VYGR 0.42
  • MACD
  • SNFCA 0.15
  • VYGR 0.12
  • Stochastic Oscillator
  • SNFCA 95.77
  • VYGR 61.33

About SNFCA Security National Financial Corporation

Security National Financial Corp is engaged in the life insurance, cemetery and mortuary, and mortgage loan businesses. The life insurance segment is engaged in the business of selling and servicing selected lines of life insurance, annuity products, and accident and health insurance. Its cemetery and mortuary segment consists of approximately seven mortuaries and five cemeteries in the state of Utah and a cemetery in the state of California. The mortgage loan segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and real estate projects. Geographically, all the business activity is functioned through the region of the USA and it derives the majority of revenue from Mortgage segment.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: